BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Susai SR, Mongan D, Healy C, Cannon M, Nelson B, Markulev C, Schäfer MR, Berger M, Mossaheb N, Schlögelhofer M, Smesny S, Hickie IB, Berger GE, Chen EYH, de Haan L, Nieman DH, Nordentoft M, Riecher-Rössler A, Verma S, Thompson A, Yung AR, McGorry PD, Föcking M, Cotter D, Amminger GP. The association of plasma inflammatory markers with omega-3 fatty acids and their mediating role in psychotic symptoms and functioning: An analysis of the NEURAPRO clinical trial. Brain Behav Immun 2021;99:147-56. [PMID: 34624483 DOI: 10.1016/j.bbi.2021.09.018] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Susai SR, Healy C, Mongan D, Heurich M, Byrne JF, Cannon M, Cagney G, Wynne K, Markulev C, Schäfer MR, Berger M, Mossaheb N, Schlögelhofer M, Smesny S, Hickie IB, Berger GE, Chen EYH, de Haan L, Nieman DH, Nordentoft M, Riecher-Rössler A, Verma S, Street R, Thompson A, Yung AR, Nelson B, McGorry PD, Föcking M, Amminger GP, Cotter D. Evidence that complement and coagulation proteins are mediating the clinical response to omega-3 fatty acids: A mass spectrometry-based investigation in subjects at clinical high-risk for psychosis. Transl Psychiatry 2022;12:454. [PMID: 36307392 DOI: 10.1038/s41398-022-02217-0] [Reference Citation Analysis]